Aarti Drugs Limited (AARTIDRUGS)
ISIN: INE767A01016 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
460
2.95(0.65%)

Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate, bisphenol – C, bisphenol – C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further, it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

462.8

TODAY'S LOW

457.1

52 WEEK HIGH

608

52 WEEK LOW

378

Major Holders

% of Shares Held by
All Insider

67.00%

% of Shares Held by
Institutions

4.56%

% of Float Held by
Institutions

13.81%

Number of Institutions
Holding Shares

18

Company Overview

MARKET CAP

4265.61 Cr.

ETERPRISE VALUE

4790.56 Cr.

NO. OF SHARES

9.26 Cr.

BOOK VALUE

119.862

DIV. YIELD

1%

DEBT

585.60 Cr.

GROSS PROFIT

786.49 Cr.

CASH

27.23 Cr.

REVENUE

2638.74 Cr.

REVENUE/SHARE

284.962

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments002.61 Cr.2.61 Cr.
Change To Liabilities117.15 Cr.-31.48 Cr.96.45 Cr.-2.48 Cr.
Total cashflows from Investing Activities-148.86 Cr.-71.67 Cr.-33.20 Cr.-61.67 Cr.
Net Borrowings195.95 Cr.-34.96 Cr.-147.82 Cr.-37.19 Cr.
Total Cash from Financing Activities92.03 Cr.-81.12 Cr.-215.40 Cr.-80.07 Cr.
Other Liabilities0000
Total Assets0000
Net Income205.04 Cr.280.41 Cr.141.40 Cr.89.75 Cr.
Change in Cash12.80 Cr.2.04 Cr.2.12 Cr.1.35 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities69.64 Cr.154.84 Cr.250.74 Cr.143.09 Cr.
Depreciation50.05 Cr.48.64 Cr.47.04 Cr.40.80 Cr.
Other Cashflows from Investing Activities3.09 Cr.5.56 Cr.1.31 Cr.1.40 Cr.
Dividends Paid-9.51 Cr.-23.20 Cr.-7.03 Cr.-2.42 Cr.
Change to Inventory-110.63 Cr.-89.18 Cr.-78.68 Cr.31.71 Cr.
Change to Account Receivables-193.87 Cr.-65.41 Cr.1.73 Cr.-62.71 Cr.
Other Cashflows from Financing Activities-20.57 Cr.-22.95 Cr.-35.16 Cr.-40.44 Cr.
Change to Net Income1.90 Cr.10.64 Cr.41.09 Cr.44.26 Cr.
Capital Expenditures-151.95 Cr.-88.13 Cr.-47.99 Cr.-74.27 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax269.95 Cr.369.01 Cr.185.28 Cr.131.02 Cr.
Minority Interest-5.97 Lakhs-1.68 Lakhs-21 k-21 k
Net Income279.37 Cr.388.12 Cr.213.41 Cr.166.05 Cr.
Selling General Administrative82.81 Cr.81.53 Cr.70.96 Cr.66.48 Cr.
Gross Profit799.79 Cr.822.91 Cr.618.51 Cr.494.70 Cr.
Ebit279.37 Cr.388.12 Cr.213.41 Cr.166.05 Cr.
Operating Income279.37 Cr.388.12 Cr.213.41 Cr.166.05 Cr.
Other Operating Expenses387.56 Cr.303.36 Cr.285.37 Cr.219.61 Cr.
Interest Expense-20.75 Cr.-22.95 Cr.-33.72 Cr.-39.95 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense64.96 Cr.88.61 Cr.43.89 Cr.41.27 Cr.
Total Revenue2488.64 Cr.2154.77 Cr.1806.08 Cr.1560.94 Cr.
Total Operating Expenses2209.27 Cr.1766.65 Cr.1592.66 Cr.1394.88 Cr.
Cost of Revenue1688.85 Cr.1331.86 Cr.1187.57 Cr.1066.23 Cr.
Total Other Income Expense Net-9.41 Cr.-19.11 Cr.-28.13 Cr.-35.03 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.204.99 Cr.280.39 Cr.141.39 Cr.89.75 Cr.
Net Income Applicable to Common Shares205.04 Cr.280.41 Cr.141.40 Cr.89.75 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets15 Lakhs25.52 Lakhs1.49 Cr.2.91 Cr.
Capital Surplus0000
Total Liabilities1171.65 Cr.852.60 Cr.924.01 Cr.912.04 Cr.
Stock Holder Equity1036.36 Cr.913.42 Cr.652.48 Cr.543.44 Cr.
Minority Interest-5.97 Lakhs-1.68 Lakhs-21 k0
Other Liabilities65.23 Cr.48.57 Cr.83.71 Cr.39.12 Cr.
Total Assets2207.96 Cr.1766.01 Cr.1576.50 Cr.1455.48 Cr.
Common Stock92.60 Cr.93.20 Cr.23.30 Cr.23.58 Cr.
Retained Earnings0801.77 Cr.614.14 Cr.504.70 Cr.
Other Liabilities91.21 Cr.106.11 Cr.114.63 Cr.112.85 Cr.
Good Will0000
Treasury Stock943.76 Cr.18.45 Cr.15.04 Cr.15.15 Cr.
Other Assets28.44 Cr.7.26 Cr.3.11 Cr.1.15 Cr.
Cash22.33 Cr.9.77 Cr.7.64 Cr.5.55 Cr.
Current Liabilities940.06 Cr.595.35 Cr.623.19 Cr.590.98 Cr.
Long Term Asset Charges0000
Short Long Term Debt399.84 Cr.39.60 Cr.41.30 Cr.35.75 Cr.
Other Stockholder Equity943.76 Cr.18.45 Cr.15.04 Cr.15.15 Cr.
Property Plant Equipment766.52 Cr.684.40 Cr.654.52 Cr.654.70 Cr.
Total Cur. Assets1393.37 Cr.1056.79 Cr.904 Cr.784.28 Cr.
Long Term Investments19.48 Cr.17.30 Cr.13.36 Cr.12.43 Cr.
Net Tangible Assets1036.21 Cr.913.16 Cr.650.99 Cr.540.53 Cr.
Short Term Investments12.64 Cr.12.20 Cr.11.42 Cr.8.92 Cr.
Net Receivables749.90 Cr.557.66 Cr.490.90 Cr.465.09 Cr.
Long Term Debt138.50 Cr.147.55 Cr.180.31 Cr.208.20 Cr.
Inventory525.94 Cr.415 Cr.325.40 Cr.246.61 Cr.
Accounts Payable468.68 Cr.329.96 Cr.329.54 Cr.242.63 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account